de Alba-Alvarado M, Cabrera-Bravo M, Zenteno E, Salazar-Schetino P, Bucio-Torres M
Pathogens. 2024; 13(10).
PMID: 39452741
PMC: 11510034.
DOI: 10.3390/pathogens13100870.
Vasconez-Gonzalez J, Mino C, Izquierdo-Condoy J, Salazar-Santoliva C, Lopez-Cortes A, Ortiz-Prado E
Trop Dis Travel Med Vaccines. 2024; 10(1):16.
PMID: 39217407
PMC: 11366139.
DOI: 10.1186/s40794-024-00227-y.
Malheiros Araujo Silvestrini M, Alessio G, Frias B, Ademar Sales Junior P, Araujo M, Silvestrini C
Front Immunol. 2024; 15:1342431.
PMID: 38655255
PMC: 11035809.
DOI: 10.3389/fimmu.2024.1342431.
Gomez I, Lopez M, Egui A, Palacios G, Carrilero B, Benitez C
PLoS Negl Trop Dis. 2023; 17(7):e0011474.
PMID: 37440604
PMC: 10368263.
DOI: 10.1371/journal.pntd.0011474.
Neves E, Koh C, Lucinda P, Souza-Silva T, Medeiros N, Pantaleao A
Clin Immunol. 2023; 251:109331.
PMID: 37088297
PMC: 10257888.
DOI: 10.1016/j.clim.2023.109331.
Risk Factors for Progression to Chronic Chagas Cardiomyopathy: A Systematic Review and Meta-Analysis.
Cutshaw M, Sciaudone M, Bowman N
Am J Trop Med Hyg. 2023; 108(4):791-800.
PMID: 36848894
PMC: 10076993.
DOI: 10.4269/ajtmh.22-0630.
Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease.
Koh C, Neves E, de Souza-Silva T, Carvalho A, Pinto C, Galdino A
Pathogens. 2023; 12(2).
PMID: 36839443
PMC: 9966322.
DOI: 10.3390/pathogens12020171.
Interleukin 10 Polymorphisms as Risk Factors for Progression to Chagas Disease Cardiomyopathy: A Case-Control Study and Meta-Analysis.
Grijalva A, Gallo Vaulet L, Aguero R, Toledano A, Risso M, Quarroz Braghini J
Front Immunol. 2022; 13:946350.
PMID: 35860267
PMC: 9289619.
DOI: 10.3389/fimmu.2022.946350.
Interleukin-32 in the Control of Acute Experimental Chagas Disease.
Braga Y, Neto J, Costa A, Silva M, Silva M, Celes M
J Immunol Res. 2022; 2022:7070301.
PMID: 35097133
PMC: 8794684.
DOI: 10.1155/2022/7070301.
Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Infection in the BALB/c Mice Model of Experimental Chagas Disease.
Soprano L, Ferrero M, Landoni M, Garcia G, Esteva M, Couto A
Front Cell Infect Microbiol. 2022; 11:814276.
PMID: 35059328
PMC: 8763857.
DOI: 10.3389/fcimb.2021.814276.
Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy.
Choudhuri S, Bhavnani S, Zhang W, Botelli V, Barrientos N, Iniguez F
Microbiol Spectr. 2021; 9(1):e0036421.
PMID: 34479416
PMC: 8552597.
DOI: 10.1128/Spectrum.00364-21.
Phenotypic and Functional Signatures of Peripheral Blood and Spleen Compartments of Cynomolgus Macaques Infected With : Associations With Cardiac Histopathological Characteristics.
Sathler-Avelar R, Vitelli-Avelar D, Mattoso-Barbosa A, Pascoal-Xavier M, Eloi-Santos S, da Costa-Rocha I
Front Cell Infect Microbiol. 2021; 11:701930.
PMID: 34336723
PMC: 8317693.
DOI: 10.3389/fcimb.2021.701930.
Risk of Recurrent Pregnancy Loss in the Ukrainian Population Using a Combined Effect of Genetic Variants: A Case-Control Study.
Loizidou E, Kucherenko A, Tatarskyy P, Chernushyn S, Livshyts G, Gulkovskyi R
Genes (Basel). 2021; 12(1).
PMID: 33466305
PMC: 7824779.
DOI: 10.3390/genes12010064.
CD14 genotype and functional dichotomy of CD14+ and CD14- cells are associated with activated immune response and development of Chagas dilated cardiomyopathy.
Costa G, da Costa Rocha M, de Souza P, Melo D, Moreira P, Gollob K
Mem Inst Oswaldo Cruz. 2020; 115:e200110.
PMID: 33146244
PMC: 7592494.
DOI: 10.1590/0074-02760200110.
IL-10-Dependent and -Independent Mechanisms Are Involved in the Cardiac Pathology Modulation Mediated by Fenofibrate in an Experimental Model of Chagas Heart Disease.
Rada J, Donato M, Penas F, Alba Soto C, Cevey A, Pieralisi A
Front Immunol. 2020; 11:572178.
PMID: 33072115
PMC: 7541836.
DOI: 10.3389/fimmu.2020.572178.
Polymorphisms in Genes Affecting Interferon-γ Production and Th1 T Cell Differentiation Are Associated With Progression to Chagas Disease Cardiomyopathy.
Frade-Barros A, Ianni B, Cabantous S, Pissetti C, Saba B, Lin-Wang H
Front Immunol. 2020; 11:1386.
PMID: 32733459
PMC: 7358543.
DOI: 10.3389/fimmu.2020.01386.
Resolvin D1 Administration Is Beneficial in Trypanosoma cruzi Infection.
Horta A, Williams T, Han B, Ma Y, Menezes A, Tu V
Infect Immun. 2020; 88(6).
PMID: 32152197
PMC: 7240093.
DOI: 10.1128/IAI.00052-20.
Association of IL18 genetic polymorphisms with Chagas disease in Latin American populations.
Strauss M, Acosta-Herrera M, Alcaraz A, Casares-Marfil D, Bosch-Nicolau P, Lo Presti M
PLoS Negl Trop Dis. 2019; 13(11):e0007859.
PMID: 31751351
PMC: 6894881.
DOI: 10.1371/journal.pntd.0007859.
Infection Enhances Toll-Like Receptors 2 and 4 Expression and Triggers TNF-α and IL-10 Production in Human Cutaneous Leishmaniasis.
Polari L, Carneiro P, Macedo M, Machado P, Scott P, Carvalho E
Front Cell Infect Microbiol. 2019; 9:120.
PMID: 31119102
PMC: 6507514.
DOI: 10.3389/fcimb.2019.00120.
Association study between CCR2-CCR5 genes polymorphisms and chronic Chagas heart disease in Wichi and in admixed populations from Argentina.
Juiz N, Estupinan E, Hernandez D, Garcilazo A, Chadi R, Morales Sanfurgo G
PLoS Negl Trop Dis. 2019; 13(1):e0007033.
PMID: 30650073
PMC: 6334923.
DOI: 10.1371/journal.pntd.0007033.